CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Earnings To Watch: Arcus Biosciences Inc (RCUS) Q2 2026 -- GF Value Sees 75% Downside

EarningsNegative
AI Analysis

Summary

Arcus Biosciences Inc (RCUS) Q2 2026 earnings are scheduled, with analyst valuation models indicating potential 75% downside to fair value.

Importance:3/10
Sentiment:
-0.50
earningsvaluationdownside
Related Companies

Read the original article

Published by yahoo_finance on August 4, 2026 1:35 PM

Read Original